Aug 13, 2020
Targeted Transcriptome Analysis Uncovers Previously Unknown Isoform Reprograming in Colon Cancer
Jun 19, 2020
TechAccel Subsidiary RNAissance Ag Completes Acquisition of St. Louis-based RNAgri
Jun 17, 2020
Sirnaomics and Precision NanoSystems Have Formed a Partnership
Jun 16, 2020
Canopy Biosciences launches interactive data analysis partnership with OnRamp BioInformatics(TM)
Jun 16, 2020
eTheRNA Raises EUR 34 Million in Series B Financing to Accelerate Multiple mRNA Therapeutic Development Programs Through to Clinical Proof of Concept
Jun 11, 2020
Sirnaomics Announces Decision to Spin off RNAimmune to Develop Novel mRNA Therapeutics and Vaccines
Jun 09, 2020
Lexogen Launches the TraPR Kit for Isolation of Functional Small RNAs
Jun 02, 2020
Moleculin Announces Emory University Clinical Trial of WP1066 Begins Enrollment
May 27, 2020
DiamiR Receives USPTO Notice of Allowance For Key Patent Covering the Use of Circulating Brain-Enriched microRNA Biomarkers for Monitoring of Brain Aging; Provides Update on Its Patent Portfolio
May 12, 2020
Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing
Apr 08, 2020
Synthesizing Oligos Just Got Faster
Apr 02, 2020
Rgenta Therapeutics Launches with $20 Million Seed Investment
Mar 30, 2020
Extracellular Vesicles From Plasma Have Higher Tumor RNA Fraction Than Platelets
Feb 28, 2020
North America & EMEA RNA Purification Life Science Dashboard 2020
Feb 28, 2020
North America & EMEA RNA Purification Life Science Dashboard 2020
Feb 28, 2020
North America & EMEA RNA Purification Life Science Dashboard 2020
Feb 20, 2020
VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update
Feb 19, 2020
Caris Life Sciences to Present at Cowen and Company 40th Annual Health Care Conference
Feb 17, 2020
Analysis of RNA Sequences and Modifications by Mass Spectrometry Published in Nature Communications
Feb 12, 2020
Study Shows That Caris Life Sciences' ADAPT Biotargeting System(TM) Has Discovered Protein Expression Pattern Differences Between Two Prostate Cancer Patient Subpopulations